High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.1M
$2,084,081
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TVTX |
Travere Therapeutics, Inc.
|
CEO
Other
|
2026-02-20 | $927,600 | M | Form 4 |
|
TVTX
S
Travere Therapeutics, Inc.
Dube Eric M
• CEO
10b5-1 SellΔOwn -12.2%
2026-02-20
$1,805,766Large
|
||||||
| TVTX |
Travere Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -12.2%
|
2026-02-20 | $1,805,766Large | S | Form 4 |
|
TVTX
M
Travere Therapeutics, Inc.
REED ELIZABETH E
• Officer • Chief Legal Officer and GC
Other
2026-02-17
$190,800
|
||||||
| TVTX |
Travere Therapeutics, Inc.
|
Officer • Chief Legal Officer and GC
Other
|
2026-02-17 | $190,800 | M | Form 4 |
|
TVTX
S
Travere Therapeutics, Inc.
REED ELIZABETH E
• Officer • Chief Legal Officer and GC
10b5-1 Sell
2026-02-17
$278,315x2
|
||||||
| TVTX |
Travere Therapeutics, Inc.
|
Officer • Chief Legal Officer and GC
10b5-1 Sell
|
2026-02-17 | $278,315x2 | S | Form 4 |